Patent · US Active

Inhibitors of hepatitis C virus

US8614207B2 · kind B2 · utility

2Cited by
11References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 9, 2012
Grant dateDec 24, 2013
Priority date
Expiry dateJul 9, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A class of compounds that inhibit Hepatitis C Virus (HCV) is disclosed, along with compositions containing the compound, and methods of using the composition for treating individuals infected with HCV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.